2011
DOI: 10.1111/j.1754-9485.2011.02243.x
|View full text |Cite
|
Sign up to set email alerts
|

Low volume contrast CTPA in patients with renal dysfunction

Abstract: Low-volume CTPA is technically feasible and provides excellent enhancement of the pulmonary arterial tree.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
5
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 27 publications
0
5
0
Order By: Relevance
“…The CM volume commonly applied in CTPA of non-obese patients varies between 60 and 100 ml [29, 33, 34]. According to the literature, a minimum attenuation value of 211 to 250 HU in PA permits reliable exclusion of acute and chronic thromboembolism [35, 36]. The mean attenuation of about 400 HU inside the PA in our study using only 40ml of CM markedly exceeded these values.…”
Section: Discussionmentioning
confidence: 48%
“…The CM volume commonly applied in CTPA of non-obese patients varies between 60 and 100 ml [29, 33, 34]. According to the literature, a minimum attenuation value of 211 to 250 HU in PA permits reliable exclusion of acute and chronic thromboembolism [35, 36]. The mean attenuation of about 400 HU inside the PA in our study using only 40ml of CM markedly exceeded these values.…”
Section: Discussionmentioning
confidence: 48%
“…Various past literature have reported on the use of a smaller dose of contrast media in CTPA[7-9]. In a former study carried out at our centre[7], we have established the feasibility of using a 75 mL of contrast in a higher concentration (350 mg/mL Iodine/Ioversol), compared to 100 mL of a standard concentration (300 mg/mL Iodine/Ioversol).…”
Section: Discussionmentioning
confidence: 94%
“…This finding was also reported in a Randomised Clinical Trial published in the same year[8], which further established the use of a lower energy tube (80 kVp vs 100 kVp) for a reduced dose of radiation. In a different single cohort study[9], the authors have evaluated the practicality of CTPA with 30 mL of contrast medium in patients with renal impairment. Although it was stated that only one out of 24 scans were non-diagnostic, the reported average opacification (247 HU) in the main pulmonary arteries is notably lower than that found in our study and is below the 250 HU threshold that we have used.…”
Section: Discussionmentioning
confidence: 99%
“…Contrast-enhanced CT arteriography has rapidly replaced ventilation-perfusion scanning as the imaging modality of choice for diagnosing PE, especially with the advent of multi-detector CT scanners that allow analysis of the pulmonary arteries and detection of emboli at the subsegmental level 26,28–30 . However, CT angiography can cause contrast medium-induced nephropathy (CIN), which is the third most common cause of in-hospital acute renal failure, 31–33 conferring significant morbidity and mortality. Therefore, a method of imaging the pulmonary vasculature without the use of contrast would represent a dramatic improvement in the risk/benefit profile of diagnostic testing for all patients suspected of having PEs and especially those who are at risk for CIN.…”
Section: Discussionmentioning
confidence: 99%